Childhood spinal muscular atrophy: controversies and challenges
Spinal muscular atrophy is an autosomal recessive disorder characterised by degeneration
of motor neurons in the spinal cord and is caused by mutations of the survival of motor …
of motor neurons in the spinal cord and is caused by mutations of the survival of motor …
New treatments in spinal muscular atrophy: an overview of currently available data
S Ramdas, L Servais - Expert opinion on pharmacotherapy, 2020 - Taylor & Francis
Introduction: Spinal muscular atrophy (SMA) is one of the most common inherited
neuromuscular disorders. It causes progressive muscle weakness and results in significant …
neuromuscular disorders. It causes progressive muscle weakness and results in significant …
New and developing therapies in spinal muscular atrophy: from genotype to phenotype to treatment and where do we stand?
TH Chen - International journal of molecular sciences, 2020 - mdpi.com
Spinal muscular atrophy (SMA) is a congenital neuromuscular disorder characterized by
motor neuron loss, resulting in progressive weakness. SMA is notable in the health care …
motor neuron loss, resulting in progressive weakness. SMA is notable in the health care …
Spinal muscular atrophies
BT Darras, JA Markowitz, UR Monani… - … disorders of infancy …, 2015 - Elsevier
Spinal muscular atrophies (SMAs) are hereditary degenerative disorders of lower motor
neurons associated with progressive muscle weakness and atrophy. Proximal 5q SMA is …
neurons associated with progressive muscle weakness and atrophy. Proximal 5q SMA is …
Prospective cohort study of spinal muscular atrophy types 2 and 3
Objective: To characterize the natural history of spinal muscular atrophy type 2 and type 3
(SMA 2/3) beyond 1 year and to report data on clinical and biological outcomes for use in …
(SMA 2/3) beyond 1 year and to report data on clinical and biological outcomes for use in …
209th ENMC international workshop: outcome measures and clinical trial readiness in spinal muscular atrophy 7–9 November 2014, Heemskerk, The Netherlands
2. Background Spinal muscular atrophy (SMA) is one of the most common neuromuscular
diseases. While SMA is a monogenic disorder, there is a broad range of phenotypes from …
diseases. While SMA is a monogenic disorder, there is a broad range of phenotypes from …
Treating pediatric neuromuscular disorders: the future is now
JJ Dowling, H D. Gonorazky, RD Cohn… - American Journal of …, 2018 - Wiley Online Library
Pediatric neuromuscular diseases encompass all disorders with onset in childhood and
where the primary area of pathology is in the peripheral nervous system. These conditions …
where the primary area of pathology is in the peripheral nervous system. These conditions …
Spinal muscular atrophy: a clinical and research update
Spinal muscular atrophy, a hereditary degenerative disorder of lower motor neurons
associated with progressive muscle weakness and atrophy, is the most common genetic …
associated with progressive muscle weakness and atrophy, is the most common genetic …
Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study
TO Crawford, SV Paushkin, DT Kobayashi, SJ Forrest… - PloS one, 2012 - journals.plos.org
Background The universal presence of a gene (SMN2) nearly identical to the mutated SMN1
gene responsible for Spinal Muscular Atrophy (SMA) has proved an enticing incentive to …
gene responsible for Spinal Muscular Atrophy (SMA) has proved an enticing incentive to …
A qualitative study of perceptions of meaningful change in spinal muscular atrophy
S McGraw, Y Qian, J Henne, J Jarecki, K Hobby… - BMC neurology, 2017 - Springer
Background This qualitative study examined how individuals with Spinal Muscular Atrophy
(SMA), their caregivers, and clinicians defined meaningful change, primarily in the Type II …
(SMA), their caregivers, and clinicians defined meaningful change, primarily in the Type II …